An orally available drug enters the brain and interferes with signaling of orexin neuropeptides—providing a potential treatment for sleep disorders and possibly addiction (pages 150–155).
References
Siegel, J.M. Annu. Rev. Psychol. 55, 125148 (2004).
Brisbare-Roch, C. et al. Nat. Med. 13, 150–155 (2007).
Peyron, C. et al. Nat. Med. 6, 991–997 (2000).
Thannickal, T.C. et al. Neuron 27, 469–474 (2000).
Crocker, A. et al. Neurology 65, 1184–1188 (2005).
Lee, M.G., Hassani, O.K. & Jones, B.E. J. Neurosci. 25, 6716–6720 (2005).
Mileykovskiy, B.Y., Kiyashchenko, L.I. & Siegel, J.M. Neuron 46, 787–798 (2005).
Estabrooke, I.V. et al. J. Neurosci. 21, 1656–1662 (2001).
Chemelli, R.M. et al. Cell 98, 437–451 (1999).
Beuckmann, C.T. et al. J. Neurosci. 24, 4469–4477 (2004).
Lin, L. et al. Cell 98, 365–376 (1999).
Mochizuki, T. et al. J. Neurosci. 24, 6291–6300 (2004).
Harris, G.C., Wimmer, M. & Aston-Jones, G. Nature 437, 556–559 (2005).
Hara, J., Yanagisawa, M. & Sakurai, T. Neurosci. Lett. 380, 239–242 (2005).
Narita, M. et al. J. Neurosci. 26, 398–405 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scammell, T., Saper, C. Orexins: looking forward to sleep, back at addiction. Nat Med 13, 126–128 (2007). https://doi.org/10.1038/nm0207-126
Issue Date:
DOI: https://doi.org/10.1038/nm0207-126
- Springer Nature America, Inc.
This article is cited by
-
A KATP channel gene effect on sleep duration: from genome-wide association studies to function in Drosophila
Molecular Psychiatry (2013)